Sandrine Lecour, PharmD, PhD, FESC, is a Professor, leader of the Cardioprotection Group and Deputy Director of the Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, South Africa. Her research group focuses on the delineation of novel cardioprotective signalling pathways, including high density lipoproteins, sphingolipids and melatonin. Over the past few years, part of her research has focussed on the delineation of a novel prosurvival path to limit ischemia-reperfusion injury which she has termed as the Survivor Activating Factor Enhancement (SAFE) pathway. She has published over 120 papers in peer-reviewed journals (H index = 39). She is on the Editorial Board of many peer-reviewed journal, including Journal of Molecular and Cellular in Cardiology, Basic Research in Cardiology, Frontiers in Physiology. She is a Committee Member of the ESC WG on Cellular Biology of the Heart and Treasurer of the ISHR European section.